Clinical trial
Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of…
NCT00466232 · HealthPartners Institute, Other · Completed
Key facts
| NCT number | NCT00466232 |
|---|---|
| Title | Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer |
| Official title | Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer |
| Lead sponsor | HealthPartners Institute, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Small Cell Carcinoma, Lung Cancer |
| Intervention type | Drug |
| Interventions | Topotecan, Sorafenib |
| Enrollment | 16 |
| Start date | Apr 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Apr 27, 2007 |
| Last update posted | Dec 16, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: